PAN-ELR+ CXC CHEMOKINE ANTIBODIES FOR THE TREATMENT OF RESPIRATORY DISEASE

摘要

Provided herein are methods and uses of antibodies that bind all seven human ELR+ CXC chemokines with high affinity for preventing and/or treating respiratory diseases, e.g., acute respiratory distress syndrome (ARDS). The present invention also relates to doses and dosing regimens for the methods and uses of antibodies that bind all seven human ELR+ CXC chemokines with high affinity for preventing and/or treating respiratory diseases, e.g., ARDS.